Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment

European Respiratory Journal

Volumn 27, Issue 4, 2006, Pages 756-760

  Barcelo A ^a   Barbe F ^b   de la Pena M ^a   Vila, M ^a   Perez G ^a   Pierola J ^a   Duran J ^c   Agusti A G N ^d  

^a Serveis de Anàlisis Cliniques   (Spain)

^b HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^c HOSPITAL TXAGORRITXU   (Spain)

^d HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Clinical trial; Continuous positive airway pressure; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL; TRIACYLGLYCEROL; URIC ACID; OXYGEN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FOLLOW UP; HUMAN; MALE; OXIDATIVE STRESS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; VITAMIN BLOOD LEVEL; BLOOD; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POLYSOMNOGRAPHY; REFERENCE VALUE;

ADULT; ANTIOXIDANTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN; POLYSOMNOGRAPHY; REFERENCE VALUES; SLEEP APNEA, OBSTRUCTIVE;

EID: 33750117317     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00067605     Document Type: Article

References (19)

1. Douglas NJ, Polo O. Pathogenesis of sleep apnoea/hypopnoea syndrome. Lancet 1994; 344: 653-655.
2. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51.
3. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162: 566-570.
4. Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AGN. Abnormal lipid peroxidation in patients with sleep apnea. Eur Respir J 2000; 16: 644-647.
5. Griendling KK, Fitzgerald GA. Oxidative stress and cardiovascular injury. Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003; 108: 1912-1916.
6. Christou K, Moulas AN, Pastaka C, Gourgoulianis KI. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 2003; 4: 225-228.
7. Lee DH, Gross MD, Jacobs JRDR. Association of serum carotenoids and tocopherols with γ-glutamyltransferase: the cardiovascular risk development in young adults (CARDIA) study. Clin Chem 2004; 50: 582-588.
8. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263-355.
9. Lee DH, Jacobs JRDR, Gross M, et al. Gamma-glutamyltrannsferase is a predictor of incident diabetes and hypertension: the coronary artery risk development in young adults (CARDIA) study. Clin Chem 2003; 49: 1358-1366.
10. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 1977; 62: 707-714.
11. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD. High density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15.
12. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults. JAMA 2002; 287: 3116-3126.
13. Steiner M. Vitamin E: more than an antioxidant. Clin Cardiol 1993; 16: I16-I18.
14. Blankenberg S, Rupprecht HJ, Bickel C, et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003; 349: 1605-1613.
15. Mangoni AA, Jackson SH. Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 2002; 112: 556-565.
16. Clarke R, Stansbie D. Assessment of homocysteine as a cardiovascular risk factor in clinical practice. Ann Clin Biochem 2001; 38: 624-632.
17. Robinson GV, Pepperell JCT, Segal HC, Davies RJO, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004; 59: 777-782.
18. Sobczak A, Wardas W, Zielinska-Danch W, Pawlicki K. The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers. Clin Chem Lab Med 2004; 42: 408-414.
19. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes P. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduce by continuous positive airway pressure therapy. Chest 2003; 124: 1386-1392.